Sciact
  • EN
  • RU

Highly efficient tumor oxygen supplementation MnO2 nano-MOF encapsulated Sorafenib for multiple synergistic CDT/PDT/RT Научная публикация

Журнал International Journal of Pharmaceutics
ISSN: 1873-3476
Вых. Данные Год: 2025, Том: 672, Номер статьи : 125328, Страниц : DOI: 10.1016/j.ijpharm.2025.125328
Авторы Guo Shuangshuang 1 , Chen Miaomiao 2 , Yang Yuhao 1 , Zhang Yuanyuan 1 , Zhuang Yuchuan 3 , Dong Yanbo 4 , Tulupov Andrey 5 , Wang Xiao 6 , Cheng Jingliang 6 , Bao Jianfeng 6 , Fan Dandan 7
Организации
1 Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450000, China.
2 School of Pharmacy, Xinyang Agriculture and Forestry University, China.
3 Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, United States.
4 Faculty of Teacher Education, Pingdingshan University, Pingdingshan, Henan 467000, China; Institute of Psychology, The Herzen State Pedagogical University of Russia, Saint Petersburg, Russia.
5 Laboratory of MRT Technologies, The Institute International Tomography Center of the Russian Academy of Sciences, Institutskaya Str. 3A, 630090 Novosibirsk, Russia.
6 Functional Magnetic Resonance and Molecular Imaging Key Laboratory of Henan Province, Department of Magnetic Resonance Imaging, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450000, China.
7 Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450000, China. Electronic address: dandanfan0725@163.com.
Библиографическая ссылка: Guo S. , Chen M. , Yang Y. , Zhang Y. , Zhuang Y. , Dong Y. , Tulupov A. , Wang X. , Cheng J. , Bao J. , Fan D.
Highly efficient tumor oxygen supplementation MnO2 nano-MOF encapsulated Sorafenib for multiple synergistic CDT/PDT/RT
International Journal of Pharmaceutics. 2025. V.672. 125328 . DOI: 10.1016/j.ijpharm.2025.125328 WOS OpenAlex
Даты:
Опубликована online: 14 февр. 2025 г.
Идентификаторы БД:
Web of science: WOS:001429249000001
OpenAlex: W4407577324
Цитирование в БД: Пока нет цитирований
Альметрики: